Drugmaker GSK recalling nearly 600,000 asthma inhalers in U.S.

(Reuters) - GSK Plc is voluntarily recalling more than 593,000 Ventolin asthma inhalers from U.S. hospitals, pharmacies, retailers and wholesalers due to a defect that may cause them to deliver fewer doses of the medicine than indicated, the British drugmaker said on Tuesday.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news